Pharmaceutical involvement in phase II breast cancer clinical trials

被引：1
|
作者：
Schneider, A.
Zhang, T.
Kamal, A.
Patel, K.
Hamilton, E. P.
Peppercorn, J. M.
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6104
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmaceutical involvement in breast cancer clinical trials.
    Peppercorn, JM
    Blood, E
    Winer, EP
    Partridge, AH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 542S - 542S
  • [2] Association between pharmaceutical involvement and outcomes in breast cancer clinical trials
    Peppercorn, Jeffrey
    Blood, Emily
    Winer, Eric
    Partridge, Ann
    [J]. CANCER, 2007, 109 (07) : 1239 - 1246
  • [3] Phase II clinical trials with rhizoxin in breast cancer and melanoma
    Hanauske, AR
    Catimel, G
    Aamdal, S
    Huinink, WT
    Paridaens, R
    Pavlidis, N
    Kaye, SB
    teVelde, A
    Wanders, J
    Verweij, J
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (03) : 397 - 399
  • [4] Phase II and III clinical trials of toremifene for metastatic breast cancer
    Vogel, CL
    [J]. ONCOLOGY-NEW YORK, 1998, 12 (03): : 9 - 13
  • [5] Pharmacogenomic predictor discovery in phase II clinical trials for breast cancer
    Pusztai, Lajos
    Anderson, Keith
    Hess, Kenneth R.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (20) : 6080 - 6086
  • [6] The role of biologic therapy in phase II breast cancer clinical trials
    Patel, K.
    Kamal, A.
    Zhang, T.
    Schneider, A.
    Hamilton, E. P.
    Peppercorn, J. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Statistical design in phase II clinical trials and its application in breast cancer
    Perrone, F
    Di Maio, M
    De Maio, E
    Maione, P
    Ottaiano, A
    Pensabene, M
    Di Lorenzo, G
    Lombardi, AV
    Signoriello, G
    Gallo, C
    [J]. LANCET ONCOLOGY, 2003, 4 (05): : 305 - 311
  • [8] Phase II Cancer Prevention Clinical Trials
    Szabo, Eva
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (04) : 359 - 366
  • [9] Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
    Cabarrou, B.
    Mourey, L.
    Dalenc, F.
    Balardy, L.
    Kanoun, D.
    Roche, H.
    Boher, J. M.
    Rouge-Bugat, M. E.
    Filleron, Thomas
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 505 - 513
  • [10] Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
    B. Cabarrou
    L. Mourey
    F. Dalenc
    L. Balardy
    D. Kanoun
    H. Roché
    J. M. Boher
    M. E. Rougé-Bugat
    Thomas Filleron
    [J]. Breast Cancer Research and Treatment, 2017, 164 : 505 - 513
12345